Pathophysiology and management of abnormal growth in children with chronic inflammatory bowel disease

World Review of Nutrition and Dietetics

Volumn 106, Issue , 2013, Pages 142-148

  Ahmed, S F ^a   Farquharson, C ^b   McGrogan, P ^a   Russell, R K ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOCORTICOID; GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; BLOOD; CHILD; CHILD DEVELOPMENT; CHRONIC DISEASE; GROWTH DISORDER; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; METABOLISM; NUTRITIONAL STATUS; PATHOPHYSIOLOGY;

CHILD; CHILD DEVELOPMENT; CHRONIC DISEASE; CYTOKINES; GLUCOCORTICOIDS; GROWTH DISORDERS; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INSULIN-LIKE GROWTH FACTOR I; NUTRITIONAL STATUS;

EID: 84875658830     PISSN: 00842230     EISSN: 16623975     Source Type: Book Series    
DOI: 10.1159/000342529     Document Type: Conference Paper

References (38)

1. Kruger HS, Pretorius R, Schutte AE: Stunting, adiposity, and low-grade inflammation in African adolescents from a township high school. Nutrition 2010;26:90-99
2. Armitage EL, Aldhous MC, Anderson N, Drummond HE, Riemersma RA, Ghosh S, Satsangi J: Incidence of juvenile-onset Crohn's disease in Scotland: Association with northern latitude and affluence. Eur J Gastroenterol Hepatol 2001;13: 1439-1447
3. Wong SC, MacRae VE, McGrogan P, Ahmed SF: The role of pro-inflammatory cytokines in inflammatory bowel disease growth retardation. J Pediatr Gastroenterol Nutr 2006;43:144-155
4. Bousvaros A, Sylvester F, Kugathasan S, Szigethy E, Fiocchi C, Colletti R, Otley A, Amre D, Ferry G, Czinn SJ, Splawski JB, Oliva-Hemker M, Hyams JS, Faubion WA, Kirschner BS, Dubinsky MC, Challenges in Pediatric IBD Study Groups: Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006;12:885-913
5. Brain CE, Savage MO: Growth and puberty in chronic inflammatory bowel disease. Baillières Clin Gastroenterol 1994;8:83-100
6. Mason A, Malik S, Russell RK, Bishop J, McGrogan P, Ahmed SF: The impact of inflammatory bowel disease on pubertal growth. Horm Res Paediatr 2011;76:293-299
7. Ballinger AB, Savage MO, Sanderson IR: Delayed puberty associated with inflammatory bowel disease. Pediatr Res 2003;53:205-210
8. Sawczenko A, Ballinger AB, Croft NM, Sanderson IR, Savage MO: Adult height in patients with early onset of Crohn's disease. Gut 2003;52:454-455
9. Kelly BP, Paterson WF, Donaldson MD: Final height outcome and value of height prediction in boys with constitutional delay in growth and adolescence treated with intramuscular testosterone 125 mg per month for 3 months. Clin Endocrinol (Oxf) 2003; 58:267-272
10. Perry RJ, Farquharson C, Ahmed SF: The role of sex steroids in controlling pubertal growth. Clin Endocrinol (Oxf) 2008;68:4-15
11. Ahmed SF, Farquharson C: The effect of GH and IGF-1 on linear growth and skeletal development and their modulation by SOCS proteins. J Endocrinol 2010;206:249-259
12. Wu Y, Sun H, Yakar S, LeRoith D: Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-1 null mice. Endocrinology 2009;150:4395-4403
13. Ballinger AB, Azooz O, El-Haj T, Poole S, Farthing MJ: Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 2000; 46:694-700
14. Wong SC, MacRae VE, Smith W, Gracie A, McInnes I, Galea P, Gardner-Medwin J, Ahmed SF: Inflammatory cytokines in juvenile idiopathic arthritis: effects on physical growth and the insulin-likegrowth factor axis. Growth Horm IGF Res 2008; 18:369-378
15. Wong SC, Smyth A, McNeill E, Galloway PJ, Hassan K, McGrogan P, Ahmed SF: The growth hormoneinsulin like growth factor 1 axis in children with inflammatory bowel disease and growth retardation. Clin Endocrinol 2010;73:220-228
16. Bechtold S, Ripperger P, Hafner R, et al: Growth hormone improves height in patients with juvenile idiopathic arthritis: 4 year data of a controlled study. J Pediatr 2003;143:512-519
17. Street ME, de'Angelis G, Camacho-Hübner C, Giovannelli G, Ziveri MA, Bacchini PL, Bernasconi S, Sansebastiano G, Savage MO: Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease. Horm Res 2004;61:159-164
18. De Benedetti F, Meazza C, Oliveri M, Pignatti P, Vivarelli M, Alonzi T, Fattori E, Garrone S, Barreca A, Martini A: Effect of IL-6 on IGF binding protein-3: A study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology 2001;142:4818-4826
19. Ahmed SF, Savendahl L: Promoting growth in chronic inflammatory disease-lessons from studies of the growth plate. Horm Res 2009;72(suppl 1): 42-47
20. Sawczenko A, Azooz O, Paraszczuk J, Idestrom M, Croft NM, Savage MO, Ballinger AB, Sanderson IR: Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the-174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci USA 2005;102:13260-13265
21. Martensson K, Chrysis D, Savendahl L: Interleukin-1beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J Bone Miner Res 2004;19:1805-1812
22. MacRae VE, Farquharson C, Ahmed SF: The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. J Endocrinol 2006;189:319-328
23. Pass C, MacRae VE, Ahmed SF, Farquharson C: SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis. J Bone Mineral Res 2012;27:1055-1566
24. MacRae VE, Horvat S, Pells S, Dale H, Collinson RS, Pitsillides AA, Ahmed SF, Farquharson C: Suppressor of cytokine signalling-2 (SOCS2) in the growing skeleton: A role in mediating the growth inhibitory effects of pro-inflammatory cytokines. J Cell Physiol 2009;218:276-284
25. Timmer A, Behrens R, Buderus S, et al: Childhood onset inflammatory bowel disease: predictors of delayed diagnosis from the CEDATA Germanlanguage pediatric inflammatory bowel disease registry. J Pediatr 2011;158:467-473
26. Bannerjee K, Camacho-Hubner C, Babinska K, et al: Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004;38:270-275
27. Owen HC, Miner JN, Ahmed SF, Farquharson C: The growth plate sparing effects of the selective glucocorticoid receptor modulator, AL-438. Mol Cell Endocrinol 2007;264:164-170
28. Malik S, Ahmed SF: Biologic therapy and its effect on growth and skeletal development in children with chronic inflammatory conditions. Exp Rev Endocrinol Metab 2010;5:733-740
29. Malik S, Wong SC, Bishop J, Hassan K, McGrogan P, Ahmed SF, Russell RK: Improvement in growth of children with Crohn disease following anti-TNF- therapy can be independent of pubertal progress and glucocorticoid reduction. J Pediatr Gastroenterol Nutr 2011;52:31-37
30. Malik S, Ahmed SF, Wilson ML, Shah N, Loganathan S, Naik S, Bourke B, Thomas A, Akobeng AK, Fagbemi A, Wilson DC, Russell RK: The effects of anti-TNF- treatment with adalimumab on growth in children with Crohn's disease (CD). J Crohn's Colitis 2012;6:337-344
31. Mason A, Wong SC, McGrogan P, Ahmed SF: The effect of testosterone therapy for delayed growth and puberty in boys with inflammatory bowel disease. Horm Res Paediatr 2011;75:8-13
32. Touati G, Prieur M, Ruiz JC, et al: Beneficial effects of one year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition. J Clin Endocrinol Metab 2004; 83:403-409
33. Denson LA, Kim MO, Bezold R, Carey R, Osuntokun B, Nylund C, Willson T, Bonkowski E, Li D, Ballard E, Collins M, Moyer MS, Klein DJ: A randomized controlled trial of growth hormone in active pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2010;51:130-139
34. Wong SC, Kumar P, Galloway PJ, Blair JC, Didi M, Dalzell AM, Hassan K, McGrogan P, Ahmed SF: A preliminary trial of the effect of recombinant human growth hormone on short-term linear growth and glucose homeostasis in children with Crohn's disease. Clin Endocrinol (Oxf) 2011;74: 599-607
35. Slonim AE, Bulone L, Damaore MB, et al: A preliminary study of growth hormone therapy for Crohn's disease. N Engl J Med 2000;342: 1633-1637
36. Savage MO, Camacho-Hubner C, Dunger DB: Therapeutic applications of insulin-like growth factors. Growth Horm IGF Res 2004;14:301-308
37. Bismuth E, Chevenne D, Czernichow P, Simon D: Moderate deterioration in glucose tolerance during high-dose growth hormone therapy in glucocorticoid-treated patients with juvenile idiopathic arthritis. Horm Res Paediatr 2010;73:465-472
38. Bucuvalas JC, Chernausek SD, Alfaro MP, Krug SK, Ritschel W, Wilmott RW: Effect of insulin-like growth factor-1 treatment in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2001;33:576-581.